ImmuCell Corporation
ICCC
$9.60+0.00%
End of day · as of Oct 12, 2026, 10:30 PM ET
Mkt cap
$58.92M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$27.64M
EPS (H1 2026)
$0.41
Gross Margin (FY2025)
41.40%
Profit Margin (FY2025)
-3.76%
Beta
0.31
Div yield
N/A
Sector
Healthcare
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Latest reported ICCC revenue for 2025-12-31 was $27.6M. Net income was -$1.0M. Revenue was up 58.2% from 2023-12-31 to 2025-12-31. ICCC currently screens at market cap $58.9M.
Use this ICCC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ICCC income, balance, and cash tables.
ImmuCell Corporation (ICCC) is a biotechnology company in the Healthcare sector.
Latest cached ImmuCell Corporation (ICCC) revenue for Dec 31, 2025 was $27.6M. Net income was -$1.0M. Statements: https://lician.com/financials/iccc
ImmuCell Corporation (ICCC) market capitalization is $58.9M on the latest cached snapshot.
ImmuCell Corporation (ICCC) cached previous close $9.60; day range $9.60 – $9.80; volume 8,260. Session quote: https://lician.com/quote/iccc
ImmuCell Corporation (ICCC) latest cached earnings event is "ICCC earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ICCC filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/iccc